4,243
Views
27
CrossRef citations to date
0
Altmetric
Editorial

The role of CD33 as therapeutic target in acute myeloid leukemia

, MD PhD MS (Epi)

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ashraf Abdullah Saad. (2022) Targeting cancer-associated glycans as a therapeutic strategy in leukemia. All Life 15:1, pages 378-433.
Read now
Sara Mongiorgi, Carlo Finelli, Yong Ryoul Yang, Cristina Clissa, James A. McCubrey, Anna Maria Billi, Lucia Manzoli, Pann-Ghill Suh, Lucio Cocco & Matilde Y. Follo. (2016) Inositide-dependent signaling pathways as new therapeutic targets in myelodysplastic syndromes. Expert Opinion on Therapeutic Targets 20:6, pages 677-687.
Read now

Articles from other publishers (25)

Christina Darwish, Kyle Farina & Douglas Tremblay. (2023) The core concepts of core binding factor acute myeloid leukemia: Current considerations for prognosis and treatment. Blood Reviews 62, pages 101117.
Crossref
Sami B. Kanaan, Francesca Urselli, Jerald P. Radich & J. Lee Nelson. (2023) Ultrasensitive chimerism enhances measurable residual disease testing after allogeneic hematopoietic cell transplantation. Blood Advances 7:20, pages 6066-6079.
Crossref
Abdul‐Habib Maag, Helen Swanton, Miriam Kull, Naidu M. Vegi & Michaela Feuring. (2023) Immunophenotypical profiling of myeloid neoplasms with erythroid predominance using mass cytometry ( CyTOF ) . Cytometry Part A 103:7, pages 551-562.
Crossref
Moazzam Shahzad, Andrea Nguyen, Ali Hussain, Mohammad Ammad-Ud-Din, Muhammad Salman Faisal, Ezza Tariq, Fatima Ali, Atif Butt, Iqra Anwar, Sibgha Gull Chaudhary, Forat Lutfi, Nausheen Ahmed, Anurag K. Singh, Peiman Hematti, Joseph P. McGuirk & Muhammad Umair Mushtaq. (2023) Outcomes with chimeric antigen receptor t-cell therapy in relapsed or refractory acute myeloid leukemia: a systematic review and meta-analysis. Frontiers in Immunology 14.
Crossref
Rui Zhang, Qingxi Liu, Sa Zhou, Hongpeng He, Mingfeng Zhao & Wenjian Ma. (2023) Engineering CAR-NK cells targeting CD33 with concomitant extracellular secretion of anti-CD16 antibody revealed superior antitumor effects toward myeloid leukemia. Cancer Letters 558, pages 216103.
Crossref
Daniela Damiani & Mario Tiribelli. (2022) Present and Future Role of Immune Targets in Acute Myeloid Leukemia. Cancers 15:1, pages 253.
Crossref
Marta Włodarczyk & Beata Pyrzynska. (2022) CAR-NK as a Rapidly Developed and Efficient Immunotherapeutic Strategy against Cancer. Cancers 15:1, pages 117.
Crossref
Pouya Safarzadeh Kozani, Abdolhossein Naseri, Seyed Mohamad Javad Mirarefin, Faeze Salem, Mojtaba Nikbakht, Sahar Evazi Bakhshi & Pooria Safarzadeh Kozani. (2022) Nanobody-based CAR-T cells for cancer immunotherapy. Biomarker Research 10:1.
Crossref
Si Wang, Xing Yan, Chang Yang & Hua Naranmandura. (2022) The Landscape of Nucleic-Acid-Based Aptamers for Treatment of Hematologic Malignancies: Challenges and Future Directions. Bioengineering 9:11, pages 635.
Crossref
Vera Weeda, Stefan G. C. Mestrum & Math P. G. Leers. (2022) Flow Cytometric Identification of Hematopoietic and Leukemic Blast Cells for Tailored Clinical Follow-Up of Acute Myeloid Leukemia. International Journal of Molecular Sciences 23:18, pages 10529.
Crossref
Cheorl-Ho KimCheorl-Ho Kim. 2022. Glycobiology of Innate Immunology. Glycobiology of Innate Immunology 631 656 .
Jackwee Lim, Duygu Sari-Ak & Tanaya Bagga. (2021) Siglecs as Therapeutic Targets in Cancer. Biology 10:11, pages 1178.
Crossref
Norman F. Russkamp, Renier Myburgh, Jonathan D. Kiefer, Dario Neri & Markus G. Manz. (2021) Anti-CD117 immunotherapy to eliminate hematopoietic and leukemia stem cells. Experimental Hematology 95, pages 31-45.
Crossref
Wanzun Lin, Jun Liu, Juhui Chen, Jiancheng Li, Sufang Qiu, Jiayu Ma, Xiandong Lin, Lurong Zhang & Junxin Wu. (2019) Peptides of tetraspanin oncoprotein CD151 trigger active immunity against primary tumour and experimental lung metastasis. eBioMedicine 49, pages 133-144.
Crossref
Xuying Pei & Xiaojun Huang. (2019) New approaches in allogenic transplantation in AML. Seminars in Hematology 56:2, pages 147-154.
Crossref
Elisabeth Paietta. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 237 279 .
Lucas A. Horn, Nicholas G. Ciavattone, Ryan Atkinson, Netsanet Woldergerima, Julia Wolf, Virginia K. Clements, Pratima Sinha, Munanchu Poudel & Suzanne Ostrand-Rosenberg. (2017) CD3xPDL1 bi-specific T cell engager (BiTE) simultaneously activates T cells and NKT cells, kills PDL1+ tumor cells, and extends the survival of tumor-bearing humanized mice. Oncotarget 8:35, pages 57964-57980.
Crossref
Huan-huan Sha, Dan-dan Wang, Da-li Yan, Yong Hu, Su-jin Yang, Si-wen Liu & Ji-feng Feng. (2017) Chimaeric antigen receptor T-cell therapy for tumour immunotherapy. Bioscience Reports 37:1.
Crossref
Piyush K. Jain, Vyas Ramanan, Arnout G. Schepers, Nisha S. Dalvie, Apekshya Panda, Heather E. Fleming & Sangeeta N. Bhatia. (2016) Development of Light-Activated CRISPR Using Guide RNAs with Photocleavable Protectors. Angewandte Chemie International Edition 55:40, pages 12440-12444.
Crossref
Piyush K. Jain, Vyas Ramanan, Arnout G. Schepers, Nisha S. Dalvie, Apekshya Panda, Heather E. Fleming & Sangeeta N. Bhatia. (2016) Development of Light-Activated CRISPR Using Guide RNAs with Photocleavable Protectors. Angewandte Chemie 128:40, pages 12628-12632.
Crossref
Feridoun Karimi-Busheri, Aghdass Rasouli-Nia & Michael Weinfeld. 2016. Biobanking and Cryopreservation of Stem Cells. Biobanking and Cryopreservation of Stem Cells 1 12 .
Nianxi Zhao, Sung-Nan Pei, Jianjun Qi, Zihua Zeng, Swaminathan P. Iyer, Pei Lin, Ching-Hsuan Tung & Youli Zu. (2015) Oligonucleotide aptamer-drug conjugates for targeted therapy of acute myeloid leukemia. Biomaterials 67, pages 42-51.
Crossref
Ying LiuXinxin HuangKhalid Amine TimaniHal E. BroxmeyerJohnny J. He. (2015) MicroRNA-124 Targets Tip110 Expression and Regulates Hematopoiesis . Stem Cells and Development 24:17, pages 2009-2017.
Crossref
D. Imrichova, L. Messingerova, M. Seres, H. Kavcova, L. Pavlikova, M. Coculova, A. Breier & Z. Sulova. (2015) Selection of resistant acute myeloid leukemia SKM-1 and MOLM-13 cells by vincristine-, mitoxantrone- and lenalidomide-induced upregulation of P-glycoprotein activity and downregulation of CD33 cell surface exposure. European Journal of Pharmaceutical Sciences 77, pages 29-39.
Crossref
Douglas G. Walker, Alexis M. Whetzel, Geidy Serrano, Lucia I. Sue, Thomas G. Beach & Lih-Fen Lue. (2015) Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex. Neurobiology of Aging 36:2, pages 571-582.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.